Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,099 JPY | -0.63% | -1.30% | +1.11% |
04-30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.11% | 42.03B | |
+31.52% | 690B | |
+24.54% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.49% | 235B | |
+4.25% | 199B | |
-10.43% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Update: Molecular Templates Scraps Experimental MT-3724 Drug, Takes Over Takeda's Myeloma Candidate